Ömür Tabak
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Clinical Biochemistry top 10%
Papers in
-
- Diabetes Treatment and Management 7
-
- Paraoxonase enzyme and polymorphisms 4
- Co-authors
- Hafize Uzun (22 shared papers)Füsun Erdenen (9 shared papers)Remise Gelışgen (14 shared papers)Reşat Özaras (8 shared papers)Hayriye Erman (3 shared papers)Fehmı Tabak (7 shared papers)Hale Nur Ertugay Aral (3 shared papers)Volkan Sözer (4 shared papers)
- Journals
- Clinical and investigative medicine (3 papers)Diabetes Obesity and Metabolism (2 papers)Biomarkers in Medicine (2 papers)Diabetes Care (2 papers)Scientific Reports (2 papers)
- Partner nations
- TürkiyeUnited StatesDenmark
In The Last Decade
Ömür Tabak
46 papers receiving 1.1k citations
Ömür Tabak's Hit Papers
Peers
Comparison fields: 5 of 95
- Endocrinology, Diabetes and Metabolism 445
- Clinical Biochemistry 54
- Hepatology 56
- Pharmacology 115
- Physiology 125
Countries citing papers authored by Ömür Tabak
This map shows the geographic impact of Ömür Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömür Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömür Tabak more than expected).
Fields of papers citing papers by Ömür Tabak
This network shows the impact of papers produced by Ömür Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömür Tabak. The network helps show where Ömür Tabak may publish in the future.
Co-authors
The 25 scholars most cited alongside Ömür Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes Hit paper breakdown → | 2019 | 390 |
| 2 | 2011 | 110 | |
| 3 | 2013 | 67 | |
| 4 | 2022 | 62 | |
| 5 | 2019 | 40 | |
| 6 | 2008 | 39 | |
| 7 | 2011 | 32 | |
| 8 | 2017 | 27 | |
| 9 | 2008 | 23 | |
| 10 | 2012 | 23 | |
| 11 | 2019 | 21 | |
| 12 | Plasma ghrelin, leptin, and orexin-A levels and insulin resistance after laparoscopic gastric band applications in morbidly obese patients. | 2013 | 20 |
| 13 | The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome. | 2016 | 19 |
| 14 | Port-related Delftia tsuruhatensis bacteremia in a patient with breast cancer. | 2013 | 19 |
| 15 | 2010 | 17 | |
| 16 | 2013 | 17 | |
| 17 | 2010 | 15 | |
| 18 | 2013 | 15 | |
| 19 | 2011 | 15 | |
| 20 | 2009 | 15 |
About Ömür Tabak
Ömür Tabak is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Epidemiology, Infectious Diseases and Surgery, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), COVID-19 Clinical Research Studies (5 papers), Paraoxonase enzyme and polymorphisms (4 papers), Lipoproteins and Cardiovascular Health (3 papers), Adipose Tissue and Metabolism (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Cardiovascular Disease and Adiposity (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (445 citations), Clinical Biochemistry (54 citations), Hepatology (56 citations), Pharmacology (115 citations) and Physiology (125 citations). Ömür Tabak has collaborated with scholars based in Türkiye, United States and Denmark. Frequent co-authors include Hafize Uzun, Füsun Erdenen, Remise Gelışgen, Reşat Özaras, Hayriye Erman, Fehmı Tabak, Hale Nur Ertugay Aral, Volkan Sözer, Veysel Tahan and Sabiha Civelek. Their work appears in journals such as Clinical and investigative medicine, Diabetes Obesity and Metabolism, Biomarkers in Medicine, Diabetes Care and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.